We are live on ! Find out more
ERNA icon

Eterna Therapeutics
ERNA

9 hedge funds and large institutions have $91.7K invested in Eterna Therapeutics in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

0.02% more ownership

Funds ownership: 0.01% → 0.03% (+0.02%)

55% less funds holding

Funds holding: 20 → 9 (-11)

65% less capital invested

Capital invested by funds: $264K → $91.7K (-$173K)

92% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 12

Holders
9
Holders Change
-11
Holders Change %
-55%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
1
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCA
Sippican Capital Advisors
Massachusetts
+$13.4K
2
Morgan Stanley
Morgan Stanley
New York
+$1.58K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.51K

Top Sellers

Rank Fund Capital Flow
1
TSS
Two Sigma Securities
New York
-$40.8K
2
Citigroup
Citigroup
New York
-$27.3K
3
CPWM
Cypress Point Wealth Management
Texas
-$16.8K
4
VPIM
Vanguard Personalized Indexing Management
California
-$12K
5
Citadel Advisors
Citadel Advisors
Florida
-$11.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
1
Geode Capital Management
Massachusetts
$36.9K +$1.51K +21 +3%
Corient Private Wealth
2
Corient Private Wealth
Florida
$32.2K – – –
SCA
3
Sippican Capital Advisors
Massachusetts
$18.4K +$13.4K +187 +88%
BlackRock
4
BlackRock
New York
$1.51K – – –
Morgan Stanley
5
Morgan Stanley
New York
$1.02K +$1.58K +22 New
UBS Group
6
UBS Group
Switzerland
$1.01K -$791 -11 -33%
AssetMark Inc
7
AssetMark Inc
California
$245 – – –
EWA
8
EverSource Wealth Advisors
Alabama
$213 – – –
Bank of America
9
Bank of America
North Carolina
$39 – – –
BNP Paribas Financial Markets
10
BNP Paribas Financial Markets
France
$18 – – –
MA
11
Montag & Associates
Georgia
$15 – – –
AWM
12
Activest Wealth Management
Florida
$6 – – –
TSS
13
Two Sigma Securities
New York
– -$40.8K -612 Closed
Citigroup
14
Citigroup
New York
– -$27.3K -408 Closed
CPWM
15
Cypress Point Wealth Management
Texas
– -$16.8K -252 Closed
VPIM
16
Vanguard Personalized Indexing Management
California
– -$12K -180 Closed
Citadel Advisors
17
Citadel Advisors
Florida
– -$11.7K -175 Closed
NW
18
Naviter Wealth
Arkansas
– -$8.24K -126 Closed
HF
19
HRT Financial
New York
– -$7K -113 Closed
XT
20
XTX Topco
Cayman Islands
– -$7.37K -110 Closed
Vanguard Group
21
Vanguard Group
Pennsylvania
– -$6.8K -102 Closed
Goldman Sachs
22
Goldman Sachs
New York
– -$3.21K -48 Closed
AWE
23
Avidian Wealth Enterprises
Texas
– -$2.63K -39 Closed
OL
24
one8zero8 LLC
North Carolina
– -$1.94K -29 Closed
Group One Trading
25
Group One Trading
Illinois
– -$3 – –
1
2

ERNA Hedge Fund Activity: Q2 2025 in Review

9 of the 7,603 institutional investors tracked by Wall St. Rank reported a position in Eterna Therapeutics (ERNA) for Q2 2025, worth a combined $91.7K — down 65% from $264K a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of ERNA and 1 opened new positions — a net loss of 11 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was Sippican Capital Advisors, adding an estimated $13.4K. The largest seller was Two Sigma Securities, exiting entirely with an estimated $40.8K sold.

  • 9 institutional investors held Eterna Therapeutics (ERNA) as of Q2 2025, down from 20 in Q1 2025.
  • Funds reported $91.7K of Eterna Therapeutics stock for Q2 2025, down 65% quarter-over-quarter.
  • 1 fund opened new Eterna Therapeutics positions in Q2 2025 and 12 closed out, a net change of -11 holders.
  • The largest Eterna Therapeutics buyer in Q2 2025 was Sippican Capital Advisors, an estimated $13.4K added.
  • The largest Eterna Therapeutics seller in Q2 2025 was Two Sigma Securities, an estimated $40.8K sold.

Based on aggregated 13F filings for Q2 2025.